Antiphospholipid antibodies (aPL) constitute a heterogeneous group of autoantibodies that
share the ability to bind phospholipids (PL) alone, protein-PL complexes, or PL-binding …

Antiphospholipid antibodies (aPL) are an heterogeneous group of circulating
immunoglobulins arising in a wide range of infectious and autoimmune diseases. Since the …

The presence of antiphospholipid antibodies (aPL) combined with venous or arterial
thrombosis, and/or obstetric complications defines the antiphospholipid syndrome (APS) …

While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β 2 glycoprotein I (anti-
β 2 GPI) antibodies represent the best available and the most widely used tests in the …

Antiphospholipid antibodies (aPL) represent a group of autoantibodies directed against
phospholipids. These antibodies may arise in a number of autoimmune conditions, of which …

The diagnosis of antiphospholipid syndrome (APS) requires the presence of both clinical
and biological features. Due to the heterogeneity of anti-phospholipid antibodies (aPL) the …

The antiphospholipid syndrome (APS) is a multi-system prothrombotic disorder associated
with circulating auto-antibodies directed against various phospholipid-binding proteins. The …

Venous and arterial thromboses are the most clinically relevant manifestations of the
Antiphospholipid S yndrome (APS)(1), whose laboratory hallmark is represented by the …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …

The antiphospholipid syndrome (APS) is an autoimmune condition characterized by
vascular thromboses and/or pregnancy morbidity, and its diagnosis currently requires …